The European Commission’s New Compulsory Licensing Proposal: A Step Forward?
The EU’s effort to establish a Union compulsory license is a step toward harmonizing patent law and creating a more effective single market.

The EU’s effort to establish a Union compulsory license is a step toward harmonizing patent law and creating a more effective single market.
The promise of COVID vaccines has been unevenly realized: fault lines have emerged between those able to secure doses and those left behind.
This post explains why Moderna’s cynical attempt to take back its COVID-19 vaccine patent pledge should fail.
For COVID treatments and diagnostics to be broadly available at affordable prices, their IP must be considered a global public good.
Putting vaccine equity at the center of a pandemic treaty will already be a huge step towards global health’s decolonization.
The pandemic has laid bare the lack of regulation for the sharing of intellectual property needed for an effective and equitable response.
Going forward, practical solutions should focus on scaling up manufacturing and supply, and improving access and affordability.
An explanation of the WTO waiver of COVID-19 intellectual property, what the U.S. declaration of support means, and likely effects of the waiver.
To secure widespread access to a COVID-19 vaccine, many countries plan to seek refuge in a long-existing strategy: compulsory licensing.